Content Type: Article

  • Healthcare Enforcement Mid-Year Roundup: 2020

    Healthcare Enforcement Mid-Year Roundup: 2020

    ARTICLE

    Healthcare Enforcement Mid-Year Roundup: 2020

    July 23, 2020

    Read time: 2 min

    Key takeaways
    Overview

    In this installment of the Healthcare Enforcement Roundup we cover new and longstanding issues impacting the healthcare enforcement landscape. First, we explore the impact of the Coronavirus (COVID-19) on the healthcare industry, and the heightened risk of enforcement actions, whistleblower complaints and litigation that arise in times of crisis. We also address differing falsity standards that have emerged under the False Claims Act (FCA), the Department of Justice’s (DOJ) FCA enforcement priorities – including an overview of the DOJ’s updated guidance on corporate compliance – and new developments on the enforceability of sub-regulatory guidance that should all be watched by hospitals, health systems and other industry stakeholders. Finally, this issue features updates on key healthcare enforcement issues to watch from past Healthcare Enforcement Roundup reports.

    In depth
    Authors

    James A. Cannatti III

    Partner

    Washington, DC

    Tony Maida

    Partner

    New York – One Vanderbilt Avenue

    Laura McLane

    Partner

    Boston

    Paul M. Thompson

    Partner

    Washington, DC

    More insights

  • HRSA Announces New Registration and Recertification Requirements for 340B Program

    HRSA Announces New Registration and Recertification Requirements for 340B Program

    ARTICLE / CLIENT ALERT

    HRSA Announces New Registration and Recertification Requirements for 340B Program

    July 22, 2020

    Read time: 7 min

    Key takeaways
    Overview

    The Office of Pharmacy Affairs (OPA) of the Health Resources and Services Administration (HRSA) recently issued a new Program Update that includes new covered entity registration and recertification requirements, as well as enhancements to the 340B Office of Pharmacy Affairs Information System (OPAIS). HRSA may be implementing these new registration requirements in order to identify and potentially take action against covered entities that HRSA believes do not qualify under a 340B covered entity category and to provide additional information to states and drug manufacturers necessary to identify and recoup duplicate discounts.

    In depth

    On July 20, 2020, the Health Resources and Services Administration (HRSA), Office of Pharmacy Affairs (OPA) issued a new Program Update with new covered entity registration and recertification requirements, as well as enhancements to the 340B Office of Pharmacy Affairs Information System (OPAIS). The Program Update focuses on documentation necessary for covered entities to demonstrate compliance with statutory 340B Program requirements. Covered entities should familiarize themselves with the Program Update in order to reduce risks of future registration delays, eligibility lapses due to missing documentation during the annual recertification process, or repayment obligations resulting from Medicaid duplicate discounts.

    Background

    In late 2019 and early 2020, the Government Accountability Office (GAO) published two reports analyzing covered entities’ compliance with certain 340B Program requirements. In the first report, published in December 2019, the GAO concluded that HRSA’s processes do not provide reasonable assurance that participating nongovernmental hospitals meet 340B Program eligibility requirements. Specifically, the GAO found that HRSA’s oversight of both the nonprofit status requirement and government contract requirement was lacking, primarily due to HRSA’s reliance on self-attestations of compliance, as well as limited and inconsistent review of verifiable primary-source documentation. For additional information, please see our On the Subject: 2020 Starts Off with Two Government Publications Critical of 340B Program Oversight.

    In the second report, published in January 2020, the GAO concluded that the US Department of Health and Human Services had provided limited oversight of the intersection of the 340B and Medicaid Drug Rebate programs, resulting in an increased risk that drug manufacturers may have paid discounts under both programs (known as “duplicate discounts”). The GAO recommended that the Centers for Medicare and Medicaid Services (CMS) begin requiring state Medicaid agencies to implement policies and procedures to prevent duplicate discounts, and that HRSA assess covered entity compliance with those policies and procedures. For additional information, please see our On the Subject: GAO Recommends CMS, HRSA Improve 340B Duplicate Discount Oversight.

    New Registration and Recertification Requirements

    Consistent with the findings in the GAO reports, HRSA issued a new Program Update on July 20, 2020, the first in more than six months, implementing certain registration and recertification requirements for covered entities. Beginning August 1, 2020, covered entities must comply with the following requirements. (Note that some requirements will only impact certain entity types.)

    1. Hospital Classification
      • Hospitals participating in the 340B Program fall into one of three classifications. Hospitals must be (1) owned or operated by a unit of state or local government; (2) nonprofit corporations that have been formally granted state or local governmental powers; or (3) private, nonprofit hospitals that have contracts with state or local governments to provide healthcare services to low-income individuals who are not eligible for Medicaid or Medicare. HRSA is now requesting documentation to support the hospital classification selected during registration to further verify the eligibility of the registering hospital.
      • For new registrations in OPAIS, the covered entity must upload supporting documentation for the “hospital classification” selected at the time of registration of a parent hospital. Hospitals changing classifications during recertification will be similarly required to upload supporting documents. Such supporting documentation may include IRS forms or letters, state letters, and copies of contracts with state or local governments.
      • This requirement is of particular importance to nonprofit hospitals participating in the 340B Program. Nonprofit hospitals eligible due to a formal grant of governmental powers should prepare documentation to demonstrate the formal grant of such powers. Nonprofit hospitals eligible due to a contract with state or local government should ensure that the required contract is available for submission during the next recertification period, is a valid contract under applicable state law, and includes the statutorily required provision of healthcare services to low-income individuals not eligible for Medicare or Medicaid.
    2. Sexually Transmitted Diseases (STD) Clinics, Tuberculosis (TB) Clinics and Ryan White HIV/AIDS (RW) Clinics
      • STD/TB/RW entities will be required to enter information regarding their Notice of Funding Opportunity (NOFO) Number, the data range of their NOFO funding, and, if applicable, the type of in-kind support they are receiving from the federal grant recipient or sub-recipient. These covered entities will be required to enter this information during registration or during the next recertification submission, as applicable.
    3. Medicaid Billing Question
      • All covered entity sites must answer the following modified Medicaid billing question when registering new locations: “At this site, will the covered entity bill Medicaid fee-for-service for drugs purchased at 340B prices?” The current question asked on OPAIS is: “Will you bill Medicaid for 340B drugs?” Thus, the modified question makes it clear that OPA is only requesting information regarding Medicaid fee-for-service, not Medicaid managed care.
      • If the covered entity answers “yes” to the Medicaid billing question for a particular location, it must also provide each Medicaid state it plans to bill and the billing number it will list on the bill to the state for services at that location. Billing number(s) may include the billing provider’s national provider identifier (NPI) only, state-assigned Medicaid number only, or both NPI and state-assigned Medicaid number. Information for new locations must be provided during initial registration, while information for currently active locations must be updated in OPAIS by the end of the covered entity’s next annual recertification period.
      • Based on the recent governmental focus on duplicate discount prevention, the information provided in response to the Medicaid billing question may be used to analyze whether drug manufacturers are being subjected to duplicate discounts. It is unclear what actions HRSA or other governmental entities may take if they discover significant instances of duplicate discounts.
      • Covered entities should review current state Medicaid billing rules, as well as state Medicaid enrollment documentation to ensure correct and complete OPAIS information on a location-specific basis.

    Analysis and Takeaways

    As a general matter, HRSA’s release of a new Program Update is somewhat unexpected, given HRSA’s responses to the GAO’s reports (suggesting that (1) its existing processes are sufficient to ensure covered entity eligibility, and (2) that it lacks regulatory authority over mechanisms to prevent duplicate discounts) and HRSA’s recent public statements regarding its inability to take enforcement action based on its own guidance and that its enforcement authority is limited to clear violations of the 340B statute. We expect that HRSA may be implementing these new registration requirements in order to identify and potentially take action against covered entities that HRSA believes do not qualify under a 340B covered entity category and to provide additional information to states and drug manufacturers necessary to identify and recoup duplicate discounts. These new requirements seem to offer greater clarity regarding the contours of HRSA’s enforcement position as of late; that is, that it intends to enforce clearly defined statutory requirements (such as the covered entity eligibility categories).

    Authors

    Emily Jane Cook

    Partner

    Los Angeles, Washington, DC

    Steven J. Schnelle

    Partner

    New York – One Vanderbilt Avenue

    Cathy Ren

    Partner

    Los Angeles

    More insights

  • Guardianship Estate Planning for Adults with Disabilities

    Guardianship Estate Planning for Adults with Disabilities

    ARTICLE / CLIENT ALERT

    Guardianship Estate Planning for Adults with Disabilities

    July 22, 2020

    Read time: 3 min

    Key takeaways
    Overview

    Guardianship estate planning statutes allow the court-appointed guardians of the estates of disabled adults to establish estate plans for their wards on petition to the court. Thirty-two states now have statutory provisions that allow estate planning of some sort undertaken by a guardian on behalf of a disabled person.

    In depth

    Among these 32 states, guardianship estate planning statutes vary but generally fall into two broad categories. In the first category, guardians have broad powers to engage in estate planning, including executing wills, codicils and trusts. Yet, only seven states allow a guardian to make a will for the disabled person, and these states vary in whether they allow the guardian to make a new will for a disabled person currently without a will, or whether they allow the guardian to make a new will for a disabled person who already has a will.

    In the second category are states that either expressly or impliedly leave out the power to make a will or a codicil for a disabled person. In some states, for example, a guardian is granted fairly broad estate planning powers, but the relevant statutes do not provide for the execution of wills or codicils. In other states, guardians are prohibited from making a will for the protected person but are authorized to create revocable or irrevocable trusts of property of the protected person’s estate. And, some states grant to guardians rather broad estate planning powers, but the power to make a will or to make gifts other than to beneficiaries authorized by the statute is expressly prohibited.

    In several states, guardianship estate planning is not available at all. In these states, a guardian has the power to manage the property and financial affairs of the protected person but is specifically prohibited from doing so by will or codicil. In other states, the guardianship statute does not refer to any estate planning powers.

    Finally, some states allow certain limited guardianship estate planning at common law. When states have common law provisions, they are typically a product of substituted judgment, which effectively limits the scope of guardianship estate planning to following through on patterns of disposition established by the disabled person at times when there was no disability.

    During our upcoming webinar, we will discuss the availability of guardianship estate planning across the United States and will outline the planning goals that can be achieved by guardians of disabled adults.

    Please join us on July 23, 2020 at 11:00 am CDT.

    Authors

    David A. Baker

    Partner

    Chicago

    More insights

  • COVID-19 Safety Plans: What Employers Need to Know

    COVID-19 Safety Plans: What Employers Need to Know

    ARTICLE

    COVID-19 Safety Plans: What Employers Need to Know

    July 21, 2020

    Read time: 1 min

    Key takeaways
    Overview
    In depth
    Authors

    Abigail M. Kagan

    Partner

    New York – One Vanderbilt Avenue

    More insights

  • Rethink Medicare’s APM Incentives to Drive Value-Based Care

    ARTICLE

    Rethink Medicare’s APM Incentives to Drive Value-Based Care

    July 20, 2020

    Read time: 1 min

    Key takeaways
    Overview
    In depth
    Authors
    More insights

  • SEC Provides Further Guidance on Covid-19 Disclosure

    SEC Provides Further Guidance on Covid-19 Disclosure

    ARTICLE

    SEC Provides Further Guidance on Covid-19 Disclosure

    July 18, 2020

    Read time: 1 min

    Key takeaways
    Overview
    In depth
    Authors

    Richard Bass

    Partner

    New York – One Vanderbilt Avenue

    Thomas P. Conaghan

    Partner

    Washington, DC, New York – One Vanderbilt Avenue

    More insights

  • The Long-Term Impact of the Pandemic on Corporate Governance

    ARTICLE

    The Long-Term Impact of the Pandemic on Corporate Governance

    July 17, 2020

    Read time: 1 min

    Key takeaways
    Overview
    In depth
    Authors

    Sandra M. DiVarco

    Partner

    Chicago

    More insights

  • Key Takeaways: Achieving Low-Cost Decarbonization Through Power Markets, Infrastructure and Grid Operations

    Key Takeaways: Achieving Low-Cost Decarbonization Through Power Markets, Infrastructure and Grid Operations

    ARTICLE

    Key Takeaways: Achieving Low-Cost Decarbonization Through Power Markets, Infrastructure and Grid Operations

    July 16, 2020

    Read time: 3 min

    Key takeaways
    Overview

    McDermott hosted Rob Gramlich, Founder and President of Grid Strategies, LLC, on July 16 for a discussion of low-cost decarbonization strategies for the electricity sector. We framed the discussion around 2020 US Presidential Candidate Joe Biden’s recently announced goal of getting to zero carbon emissions from the electricity grid by 2035.

    In depth

    Here are three takeaways from our conversation:

    1. Three Areas of Change. Rob highlighted three areas where improvements can be made to substantially increase the deployment of wind and solar resources: Power markets, grid infrastructure and grid operations. With respect to power markets, Rob emphasized that regional transmission organizations (RTOs) can play a bigger role in achieving very fast dispatch over large geographic areas. With respect to infrastructure, he emphasized that new transmission lines will be required to reach the best wind and solar resources, but also that many of those new lines can be built on existing rights-of-way. And with respect to grid operations, he emphasized that there are technologies and operating practices that can help us improve the efficiency of the grid.
    2. Flexible FERC. Rob suggested that under a new Democratic administration, FERC would likely prioritize flexibility in pricing design and in FERC’s interactions with states. He emphasized the importance of a flexible design for the pricing of “capacity” services and suggested that a Biden administration would likely be supportive of state level efforts to promote renewable energy.
    3. Transmission Costs vs. Electricity Costs. Rob suggested that over the next ten years transmission costs will become a greater share of the overall cost of electricity, but that building out transmission would help bring that overall cost down.

    Listen to the full webinar.

    To begin receiving Energy updates, including invitations to the webinar series, please click here.

    Authors

    Jacob Hollinger

    Partner

    New York – One Vanderbilt Avenue

    Edward Zaelke

    Partner

    Los Angeles

    More insights

  • Preparing for Battle: How to Build Your Litigation Defenses Now

    Preparing for Battle: How to Build Your Litigation Defenses Now

    ARTICLE

    Preparing for Battle: How to Build Your Litigation Defenses Now

    July 15, 2020

    Read time: 1 min

    Key takeaways
    Overview
    In depth
    Authors

    Brian Mead

    Partner

    Chicago

    More insights

  • Automotive Finance Update – The Digital Point of Sale

    Automotive Finance Update – The Digital Point of Sale

    ARTICLE / CLIENT ALERT

    Automotive Finance Update – The Digital Point of Sale

    July 15, 2020

    Read time: 6 min

    Key takeaways
    Overview

    Legal aspects to consider when digitalizing the execution of automotive finance contracts at the dealership

    In recent years, in order to increase sales, car manufacturers have increasingly integrated the provision of finance products into the customer’s car purchase experience at the car dealer-ship, regardless of whether such finance products are provided by the manufacturer’s captive bank or through cooperations with a white label financing provider. More and more dealers, car manufacturers and financing providers are now looking further digitalize the interaction with their customers. The goal is to reduce time and effort spent on executing documentation and meeting KYC requirements. Ideally, the customer provides his signatures and any KYC documentation digitally on a tablet or smartphone without having to print out any documents.

    In order to achieve this goal, financing providers and dealers have started to cooperate with FinTechs which offer apps that promise a digitalization of the whole process around the execution of the finance products.

    With a view to any of these projects, there are a number of aspects under German law that the financing providers and the dealers should keep in mind. These include statutory form requirements and compliance with anti-money laundering law provisions or consumer protection laws. Furthermore, compliance with data protection laws is more important than ever in the light of recent legislative developments such as the General Data Protection Regulation.

    In this alert, we provide a short overview over some of the legal obstacles that arise in connection with the digitalization of the sales process at car dealerships.

    In depth

    Consumer protection and Compliance with form requirements

    Consumer protection laws may apply. This can be the case for two different reasons. First, the financing agreement in question may be a distance contract (Fernabsatzvertrag) according to section 312c German Civil Code (Bürgerliches Gesetzbuch, “BGB”) if the financing provider and a consumer (Verbraucher) exclusively avail themselves of means of distance communication on negotiating and concluding the contract except where the conclusion of the contract does not take place in the context of a sales or service-provision scheme organized for distance sales. In order to determine whether a financing agreement in fact constitutes a distance contract, a case-by-case evaluation is necessary.

    Secondly, the contract could also be classified as a consumer loan (section 491 (1) BGB) or a non-gratuitous financing assistance (entgeltliche Finanzierungshilfe, section 506 (1) BGB). With regards to the latter, there is widespread debate whether the provisions regarding non-gratuitous financing assistance are applicable by way of analogy to leasing contracts with mileage allowance.1 Considering this question has not yet been decided by Germany’s Federal Court of Justice (Bundesgerichtshof), many companies decide to comply with the respective consumer protection provisions just in case.

    If consumer protection laws apply, the seller has to provide the buyer with a broad range of legal information on, inter alia, the consumer’s right to revoke the contract. The means by which such information are to be provided depends on the specific contract in question. Also, if the contract is qualified as a consumer loan agreement or a non-gratuitous financing assistance, then it needs to be concluded in written form (Schriftform). Generally, that requires that a physical document is signed by each party by hand and then physically provided to the contractual partner.

    Instead of having the customer sign the paperwork by hand, it is also possible to use qualified electronic signatures which under German law satisfy the written form requirement (so-called electronic form, elektronische Form, section 126a BGB). When using an electronic signature, a graphic is digitally generated under the document. Thereby the identity of the signatory is verified and the integrity of the document can be guaranteed. Therefore, the use of the apps mentioned above can help to meet formal requirements for the conclusion of contracts more easily. However, before accepting a customer’s electronic signature under a document, financing providers should always verify that the technology provider takes the necessary steps to comply with the respective requirements under European and German law regarding the electronic form.

    Anti-money laundering regulation

    When entering into financing agreements, anti-money laundering provisions have to be complied with. According to section 2 (1) of the German Money Laundering Act (Geldwäschegesetz, “MLA”), banks and other financial institutions are obliged entities under the MLA. As a result, they have to identify their contracting parties and, if applicable, persons acting on their behalf, before establishing a business relationship or executing a transaction (section 10 (1) and 11 (1) MLA). Pursuant to section 13 (1) MLA, the obliged entity has to examine the document presented physically or may employ another equally suitable procedure. This requirement does not necessarily have to be fulfilled by the obliged entity itself. A third party which is either an obliged entity under the MLA (section 17 (1) MLA) or another suitable person/company (section 17 (5) MLA) can be engaged in this process. If a financing provider uses an application to verify customers’ identities, however, it must comply with provisions regarding the outsourcing of KYC procedures and it is obligated to, inter alia, conduct random checks of the application provider’s work.

    Outlook

    If done right, the digitalization of point of sale processes can improve the customer journey without compromising the legal validity of the execution or bearing any other risks for the dealer and the financing provider. Authentication apps can be a useful tool to simplify the process of contract conclusion and offer the consumer a more comfortable option to provide all relevant information.

    ***

    – 1   For further information on this issue please refer to the McDermott Will & Emery Automotive Finance Update – Recent court decisions in Germany regarding consumer protection under leasing agreements with mileage allowance, /insights/automotive-finance-update-recent-court-decisions-in-germany-regarding-consumer-protection-underleasing-agreements-with-mileage-allowance/

    Authors
    More insights